Aryl / hetaryl substituted imidazoquinolines

Disclosed is a compound of formula (II) wherein the substituents are disclosed within the specification. Also disclosed is the use of the above compound of formula (II) in the manufacture of a pharmaceutical composition for inducing cytokine biosynthesis in an animal, for treating a viral disease in...

Full description

Saved in:
Bibliographic Details
Main Authors RADMER, MATTHEW RONALD, LINDSTROM, KYLE JON, JOHANNESSEN, SARAH CHRISTINE, PRINCE, RYAN BENJAMIN, SQUIRE, DAVID JOSEPH, NIWAS, SHRI, RICE, MICHAEL JOHN, WURST, JOSHUA RAYMOND, GUPTA, SHALLEY KANT, KSHIRSAGAR, TUSHAR, GHOSH, TARUN KANTI, BONK, JASON DANIEL, DANIELSON, MICHAEL EDWIN, HAYS, DAVID SCOTT, HEPPNER, PHILIP DALE, KAVANAGH, MAUREEN ANN, HARALDSON, CHAD ALAN, STRONG, SARAH ANN, GERSTER, JOHN FRANKLIN, MERRILL, BRYON ANDERSON
Format Patent
LanguageEnglish
Published 31.07.2008
Edition7
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:Disclosed is a compound of formula (II) wherein the substituents are disclosed within the specification. Also disclosed is the use of the above compound of formula (II) in the manufacture of a pharmaceutical composition for inducing cytokine biosynthesis in an animal, for treating a viral disease in an animal, or for treating a neoplastic disease in an animal.
Bibliography:Application Number: NZ20030540826